Icosavax, Inc. (ICVX) NASDAQ
$15.31 (0.14) (-0.91%)
Market Cap: $769.04M
As of 02/16/24 04:00 PM EST. Market closed.
Icosavax, Inc. (ICVX)
NASDAQ
$15.31
(0.14) (-0.91%)
Market Cap: $769.04M
As of 02/16/24 04:00 PM EST. Market closed.
Add to Portfolio
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Adam K. Simpson
Full Time Employees
60
CEO Compensation (Base)
$580,000
CEO Compensation (Total)
$6.91M
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Adam K. Simpson
Full Time Employees
60
CEO Compensation (Base)
$580,000
CEO Compensation (Total)
$6.91M
URL
Address
1616 Eastlake Avenue East, WA, Seattle, 98102.
PRICE CHART FOR ICOSAVAX, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$15.40
Previous Close
$15.45
Days Range
$15.28 - $15.44
52 week range
$4.75 - $16.11
Volume
8,556,852
Avg. Volume (30 days)
1,053,296
Market Cap
$769.04M
Dividend Yield
-
P/E
(6.96)
Shares Outstanding
50,231,000
Open
$15.40
Previous Close
$15.45
Days Range
$15.28 - $15.44
52 week range
$4.75 - $16.11
Volume
8,556,852
Avg. Volume (30 days)
1,053,296
Market Cap
$769.04M
Dividend Yield
-
P/E
(6.96)
Shares Outstanding
50,231,000
FINANCIAL STATEMENTS FOR ICOSAVAX, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ICOSAVAX, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Simpson Adam K. | Chief Executive Officer | Feb 01, 2024 | Option Exercise | $1.04 | 15,000 | 15,600 | 373,657 | Feb 02, 2024, 07:03 PM |
| Simpson Adam K. | Chief Executive Officer | Feb 01, 2024 | Sale | $15.29 | 15,000 | 229,386 | 358,657 | Feb 02, 2024, 07:03 PM |
| Simpson Adam K. | Chief Executive Officer | Jan 22, 2024 | Option Exercise | $1.03 | 98,016 | 100,979 | 358,657 | Jan 23, 2024, 06:15 PM |
| Kanesa-thasan Niranjan | Chief Medical Officer | Jan 04, 2023 | Option Exercise | $2.34 | 106,373 | 249,298 | 330,353 | Jan 05, 2024, 07:18 PM |
| Kanesa-thasan Niranjan | Chief Medical Officer | Jan 04, 2023 | Sale | $15.70 | 106,373 | 1,670,460 | 223,980 | Jan 05, 2024, 07:18 PM |
| Simpson Adam K. | Chief Executive Officer | Jan 02, 2024 | Option Exercise | $1.04 | 15,000 | 15,600 | 275,641 | Jan 04, 2024, 05:05 PM |
| Simpson Adam K. | Chief Executive Officer | Jan 02, 2024 | Sale | $15.67 | 15,000 | 235,087 | 260,641 | Jan 04, 2024, 05:05 PM |
| Simpson Adam K. | Chief Executive Officer | Dec 21, 2023 | Option Exercise | $1.36 | 165,917 | 225,085 | 350,641 | Dec 22, 2023, 06:27 PM |
| Simpson Adam K. | Chief Executive Officer | Dec 21, 2023 | Sale | $15.44 | 90,000 | 1,389,280 | 300,641 | Dec 22, 2023, 06:27 PM |
| Simpson Adam K. | Chief Executive Officer | Dec 20, 2023 | Sale | $15.46 | 62,205 | 961,509 | 184,724 | Dec 22, 2023, 06:27 PM |
| Russo Thomas Joseph | Chief Financial Officer | Dec 20, 2023 | Sale | $15.46 | 15,183 | 234,720 | 42,467 | Dec 22, 2023, 06:26 PM |
| Kanesa-thasan Niranjan | Chief Medical Officer | Dec 20, 2023 | Sale | $15.46 | 11,884 | 183,692 | 223,980 | Dec 22, 2023, 06:25 PM |
| Cearley Cassia | Chief Business Officer | Dec 20, 2023 | Sale | $15.46 | 7,934 | 122,637 | 130,694 | Dec 22, 2023, 06:24 PM |
| Cearley Cassia | Chief Business Officer | Dec 13, 2023 | Sale | $16.01 | 8,759 | 140,190 | 131,200 | Dec 15, 2023, 07:35 PM |
| Simpson Adam K. | Chief Executive Officer | Aug 01, 2023 | Option Exercise | $0.84 | 3,000 | 2,520 | 246,930 | Aug 01, 2023, 08:54 PM |
| Kanesa-thasan Niranjan | Chief Medical Officer | Jul 31, 2023 | Sale | $8.86 | 3,323 | 29,447 | 235,864 | Aug 01, 2023, 08:32 PM |
| Simpson Adam K. | Chief Executive Officer | Jul 31, 2023 | Sale | $8.86 | 11,788 | 104,459 | 243,930 | Aug 01, 2023, 08:30 PM |
| Russo Thomas Joseph | Chief Financial Officer | Jul 31, 2023 | Sale | $8.86 | 3,066 | 27,169 | 45,620 | Aug 01, 2023, 08:28 PM |
| Cearley Cassia | Chief Business Officer | Jul 31, 2023 | Sale | $8.86 | 1,888 | 16,731 | 139,959 | Aug 01, 2023, 08:24 PM |
| Holtzman Douglas | Chief Scientific Officer | Jul 03, 2023 | Option Exercise | $1.04 | 16,356 | 17,010 | 306,410 | Jul 03, 2023, 07:43 PM |
| Holtzman Douglas | Chief Scientific Officer | Jul 03, 2023 | Sale | $8.85 | 16,356 | 144,743 | 292,149 | Jul 03, 2023, 07:43 PM |
| Cearley Cassia | Chief Business Officer | May 23, 2023 | Sale | $10.00 | 10,000 | 100,000 | 141,847 | May 25, 2023, 07:39 PM |
| Holtzman Douglas | Chief Scientific Officer | Apr 03, 2023 | Option Exercise | $1.04 | 20,443 | 21,261 | 310,497 | Apr 05, 2023, 07:12 PM |
| Holtzman Douglas | Chief Scientific Officer | Apr 03, 2023 | Sale | $6.09 | 20,443 | 124,407 | 290,354 | Apr 05, 2023, 07:12 PM |
| Cearley Cassia | Chief Business Officer | Mar 06, 2023 | Sale | $7.75 | 5,000 | 38,737 | 151,847 | Mar 08, 2023, 05:45 PM |
| Simpson Adam K. | Chief Executive Officer | Feb 15, 2023 | Option Exercise | $1.04 | 10,677 | 11,104 | 255,718 | Feb 16, 2023, 08:00 PM |
| Bekiroglu Elizabeth | General Counsel & Corp. Sec. | Feb 13, 2023 | Sale | $10.69 | 5,922 | 63,322 | 103,007 | Feb 15, 2023, 08:12 PM |
| Simpson Adam K. | Chief Executive Officer | Feb 13, 2023 | Sale | $10.69 | 7,506 | 80,259 | 245,041 | Feb 15, 2023, 08:09 PM |
| Holtzman Douglas | Chief Scientific Officer | Feb 14, 2023 | Sale | $10.17 | 3,349 | 34,064 | 290,054 | Feb 15, 2023, 08:07 PM |
| Holtzman Douglas | Chief Scientific Officer | Feb 13, 2023 | Sale | $10.69 | 1,522 | 16,274 | 293,403 | Feb 15, 2023, 08:07 PM |
| Russo Thomas Joseph | Chief Financial Officer | Feb 13, 2023 | Sale | $10.69 | 1,902 | 20,337 | 48,686 | Feb 15, 2023, 08:04 PM |
| Kanesa-thasan Niranjan | Chief Medical Officer | Feb 13, 2023 | Sale | $10.69 | 1,794 | 19,183 | 239,187 | Feb 15, 2023, 07:58 PM |
| Cearley Cassia | Chief Business Officer | Feb 13, 2023 | Sale | $10.69 | 1,660 | 17,750 | 156,847 | Feb 15, 2023, 07:56 PM |
| Cearley Cassia | Chief Business Officer | Jan 30, 2023 | Option Exercise | $0.84 | 25,102 | 21,086 | 156,840 | Jan 31, 2023, 04:19 PM |
| Simpson Adam K. | Chief Executive Officer | Jan 25, 2023 | Option Exercise | $1.00 | 13,073 | 13,117 | 252,547 | Jan 27, 2023, 05:02 PM |
| Simpson Adam K. | Chief Executive Officer | Dec 23, 2022 | Option Exercise | $0.84 | 14,369 | 12,070 | 239,474 | Dec 23, 2022, 07:00 PM |
| Simpson Adam K. | Chief Executive Officer | Dec 21, 2022 | Sale | $8.96 | 66,764 | 598,406 | 225,105 | Dec 23, 2022, 07:00 PM |
| Holtzman Douglas | Chief Scientific Officer | Dec 15, 2022 | Sale | $11.14 | 19,648 | 218,963 | 2,792 | Dec 16, 2022, 06:36 PM |
| Bekiroglu Elizabeth | General Counsel & Corp. Sec. | Sep 08, 2022 | Sale | $4.87 | 1,813 | 8,835 | 108,929 | Sep 09, 2022, 06:44 PM |
| Simpson Adam K. | Chief Executive Officer | Aug 02, 2022 | Sale | $6.70 | 1,904 | 12,764 | 291,869 | Aug 02, 2022, 09:47 PM |
| Simpson Adam K. | Chief Executive Officer | Aug 01, 2022 | Sale | $6.64 | 7,017 | 46,575 | 293,772 | Aug 02, 2022, 09:47 PM |
| Simpson Adam K. | Chief Executive Officer | Jul 29, 2022 | Sale | $7.11 | 2,456 | 17,456 | 300,789 | Aug 02, 2022, 09:47 PM |
| Russo Thomas Joseph | Chief Financial Officer | Aug 02, 2022 | Sale | $6.70 | 495 | 3,318 | 48,921 | Aug 02, 2022, 09:43 PM |
| Russo Thomas Joseph | Chief Financial Officer | Aug 01, 2022 | Sale | $6.64 | 1,825 | 12,113 | 49,416 | Aug 02, 2022, 09:43 PM |
| Russo Thomas Joseph | Chief Financial Officer | Jul 29, 2022 | Sale | $7.11 | 639 | 4,542 | 51,241 | Aug 02, 2022, 09:43 PM |
| Holtzman Douglas | Chief Scientific Officer | Aug 02, 2022 | Sale | $6.70 | 453 | 3,037 | 293,258 | Aug 02, 2022, 09:42 PM |
| Holtzman Douglas | Chief Scientific Officer | Aug 01, 2022 | Sale | $6.64 | 9,337 | 61,973 | 293,711 | Aug 02, 2022, 09:42 PM |
| Holtzman Douglas | Chief Scientific Officer | Jul 29, 2022 | Sale | $7.11 | 585 | 4,158 | 303,048 | Aug 02, 2022, 09:42 PM |
| Richardson Charles E | SVP, Technical Operations | Aug 02, 2022 | Sale | $6.70 | 371 | 2,487 | 165,168 | Aug 02, 2022, 09:40 PM |
| Richardson Charles E | SVP, Technical Operations | Aug 01, 2022 | Sale | $6.64 | 1,368 | 9,080 | 165,539 | Aug 02, 2022, 09:40 PM |
| Richardson Charles E | SVP, Technical Operations | Jul 29, 2022 | Sale | $7.11 | 479 | 3,405 | 166,907 | Aug 02, 2022, 09:40 PM |
| Kanesa-thasan Niranjan | Chief Medical Officer | Aug 02, 2022 | Sale | $6.70 | 543 | 3,640 | 239,314 | Aug 02, 2022, 09:37 PM |
| Kanesa-thasan Niranjan | Chief Medical Officer | Aug 01, 2022 | Sale | $6.64 | 2,001 | 13,281 | 239,857 | Aug 02, 2022, 09:37 PM |
| Kanesa-thasan Niranjan | Chief Medical Officer | Jul 29, 2022 | Sale | $7.11 | 701 | 4,982 | 241,858 | Aug 02, 2022, 09:37 PM |
| Cearley Cassia | Chief Business Officer | Aug 02, 2022 | Sale | $6.70 | 303 | 2,031 | 131,738 | Aug 02, 2022, 09:34 PM |
| Cearley Cassia | Chief Business Officer | Aug 01, 2022 | Sale | $6.64 | 1,118 | 7,421 | 132,041 | Aug 02, 2022, 09:34 PM |
| Cearley Cassia | Chief Business Officer | Jul 29, 2022 | Sale | $7.11 | 391 | 2,779 | 133,159 | Aug 02, 2022, 09:34 PM |
| Simpson Adam K. | Chief Executive Officer | Jul 01, 2022 | Option Exercise | $0.84 | 7,185 | 6,035 | 303,245 | Jul 06, 2022, 06:53 PM |
| MCDADE MARK | Director | Apr 01, 2022 | Buy | $7.10 | 42,225 | 299,797 | 50,243 | Apr 05, 2022, 04:10 PM |
| Simpson Adam K. | Chief Executive Officer | Mar 28, 2022 | Option Exercise | $0.84 | 4,789 | 4,023 | 220,482 | Mar 30, 2022, 06:42 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Mar 29, 2022 | Buy | $4.75 | 8,900 | 42,271 | 5,963,565 | Mar 30, 2022, 04:31 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Mar 28, 2022 | Buy | $4.53 | 175,318 | 794,611 | 5,953,665 | Mar 30, 2022, 04:31 PM |
| Cearley Cassia | Chief Business Officer | Mar 18, 2022 | Option Exercise | $0.84 | 35,137 | 29,515 | 133,550 | Mar 22, 2022, 04:36 PM |
| Cearley Cassia | Chief Business Officer | Mar 07, 2022 | Sale | $17.16 | 10,000 | 171,629 | 98,897 | Mar 09, 2022, 05:34 PM |
| Richardson Charles E | SVP, Technical Operations | Feb 14, 2022 | Option Exercise | $0.86 | 72,561 | 62,188 | 167,386 | Feb 16, 2022, 05:22 PM |
| Kanesa-thasan Niranjan | Chief Medical Officer | Feb 02, 2022 | Option Exercise | $0.99 | 52,752 | 52,101 | 221,408 | Feb 04, 2022, 06:25 PM |
| Simpson Adam K. | Chief Executive Officer | Jan 26, 2022 | Option Exercise | $1.00 | 90,693 | 90,968 | 215,693 | Jan 28, 2022, 06:04 PM |
| Cearley Cassia | Chief Business Officer | Nov 15, 2021 | Option Exercise | $0.83 | 22,598 | 18,756 | 85,491 | Nov 17, 2021, 05:13 PM |
| NanoDimension III, L.P. | Former 10% Owner | Aug 02, 2021 | Buy | $15.00 | 133,334 | 2,000,010 | 2,883,329 | Aug 04, 2021, 06:20 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Aug 02, 2021 | Buy | $15.00 | 2,666,666 | 39,999,990 | 5,140,679 | Aug 04, 2021, 04:31 PM |
| Gould Terry P | Director | Aug 02, 2021 | Buy | $15.00 | 133,334 | 2,000,010 | 996,169 | Aug 03, 2021, 06:56 PM |
| ADAMS STREET PARTNERS LLC | Former 10% Owner | Aug 02, 2021 | Buy | $15.00 | 133,334 | 2,000,010 | 996,169 | Aug 03, 2021, 06:24 PM |
| Richardson Charles E | See Remarks | Jul 30, 2021 | Option Exercise | $15.00 | 27,750 | 416,250 | 78,883 | Aug 02, 2021, 09:32 PM |
| Cearley Cassia | Chief Business Officer | Jul 30, 2021 | Option Exercise | $15.00 | 27,750 | 416,250 | 62,893 | Aug 02, 2021, 09:29 PM |
| Veneman Ann M | Director | Jul 30, 2021 | Option Exercise | $15.00 | 8,500 | 127,500 | 8,500 | Aug 02, 2021, 09:27 PM |
| Qiming U.S. Healthcare Fund II, L.P. | Former 10% Owner | Aug 02, 2021 | Buy | $15.00 | 221,351 | 3,320,265 | 3,523,561 | Aug 02, 2021, 09:27 PM |
| Holtzman Douglas | Chief Scientific Officer | Jul 30, 2021 | Option Exercise | $15.00 | 41,500 | 622,500 | 282,482 | Aug 02, 2021, 09:26 PM |
| FIELDS HEIDI | Director | Jul 30, 2021 | Option Exercise | $15.00 | 8,750 | 131,250 | 8,750 | Aug 02, 2021, 09:25 PM |
| Simpson Adam K. | Chief Executive Officer | Jul 30, 2021 | Option Exercise | $15.00 | 125,000 | 1,875,000 | 125,000 | Aug 02, 2021, 09:23 PM |
| Kanesa-thasan Niranjan | Chief Medical Officer | Jul 30, 2021 | Option Exercise | $15.00 | 41,500 | 622,500 | 168,656 | Aug 02, 2021, 09:20 PM |
| Kanesa-thasan Niranjan | Chief Medical Officer | Aug 02, 2021 | Buy | $15.00 | 6,666 | 99,990 | 6,666 | Aug 02, 2021, 09:20 PM |
| Russo Thomas Joseph | Chief Financial Officer | Jul 30, 2021 | Option Exercise | $15.00 | 32,500 | 487,500 | 32,500 | Aug 02, 2021, 09:19 PM |
| Sanofi | 10% Owner | Aug 02, 2021 | Buy | $15.00 | 66,667 | 1,000,005 | 3,155,169 | Aug 02, 2021, 08:34 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Simpson Adam K. | Chief Executive Officer | 02/01/2024 | 15,600 |
| Simpson Adam K. | Chief Executive Officer | 02/01/2024 | 229,386 |
| Simpson Adam K. | Chief Executive Officer | 01/22/2024 | 100,979 |
| Kanesa-thasan Niranjan | Chief Medical Officer | 01/04/2023 | 249,298 |
| Kanesa-thasan Niranjan | Chief Medical Officer | 01/04/2023 | 1,670,460 |
| Simpson Adam K. | Chief Executive Officer | 01/02/2024 | 15,600 |
| Simpson Adam K. | Chief Executive Officer | 01/02/2024 | 235,087 |
| Simpson Adam K. | Chief Executive Officer | 12/21/2023 | 225,085 |
| Simpson Adam K. | Chief Executive Officer | 12/21/2023 | 1,389,280 |
| Simpson Adam K. | Chief Executive Officer | 12/20/2023 | 961,509 |
| Russo Thomas Joseph | Chief Financial Officer | 12/20/2023 | 234,720 |
| Kanesa-thasan Niranjan | Chief Medical Officer | 12/20/2023 | 183,692 |
| Cearley Cassia | Chief Business Officer | 12/20/2023 | 122,637 |
| Cearley Cassia | Chief Business Officer | 12/13/2023 | 140,190 |
| Simpson Adam K. | Chief Executive Officer | 08/01/2023 | 2,520 |
| Kanesa-thasan Niranjan | Chief Medical Officer | 07/31/2023 | 29,447 |
| Simpson Adam K. | Chief Executive Officer | 07/31/2023 | 104,459 |
| Russo Thomas Joseph | Chief Financial Officer | 07/31/2023 | 27,169 |
| Cearley Cassia | Chief Business Officer | 07/31/2023 | 16,731 |
| Holtzman Douglas | Chief Scientific Officer | 07/03/2023 | 17,010 |
| Holtzman Douglas | Chief Scientific Officer | 07/03/2023 | 144,743 |
| Cearley Cassia | Chief Business Officer | 05/23/2023 | 100,000 |
| Holtzman Douglas | Chief Scientific Officer | 04/03/2023 | 21,261 |
| Holtzman Douglas | Chief Scientific Officer | 04/03/2023 | 124,407 |
| Cearley Cassia | Chief Business Officer | 03/06/2023 | 38,737 |
| Simpson Adam K. | Chief Executive Officer | 02/15/2023 | 11,104 |
| Bekiroglu Elizabeth | General Counsel & Corp. Sec. | 02/13/2023 | 63,322 |
| Simpson Adam K. | Chief Executive Officer | 02/13/2023 | 80,259 |
| Holtzman Douglas | Chief Scientific Officer | 02/14/2023 | 34,064 |
| Holtzman Douglas | Chief Scientific Officer | 02/13/2023 | 16,274 |
| Russo Thomas Joseph | Chief Financial Officer | 02/13/2023 | 20,337 |
| Kanesa-thasan Niranjan | Chief Medical Officer | 02/13/2023 | 19,183 |
| Cearley Cassia | Chief Business Officer | 02/13/2023 | 17,750 |
| Cearley Cassia | Chief Business Officer | 01/30/2023 | 21,086 |
| Simpson Adam K. | Chief Executive Officer | 01/25/2023 | 13,117 |
| Simpson Adam K. | Chief Executive Officer | 12/23/2022 | 12,070 |
| Simpson Adam K. | Chief Executive Officer | 12/21/2022 | 598,406 |
| Holtzman Douglas | Chief Scientific Officer | 12/15/2022 | 218,963 |
| Bekiroglu Elizabeth | General Counsel & Corp. Sec. | 09/08/2022 | 8,835 |
| Simpson Adam K. | Chief Executive Officer | 08/02/2022 | 12,764 |
| Simpson Adam K. | Chief Executive Officer | 08/01/2022 | 46,575 |
| Simpson Adam K. | Chief Executive Officer | 07/29/2022 | 17,456 |
| Russo Thomas Joseph | Chief Financial Officer | 08/02/2022 | 3,318 |
| Russo Thomas Joseph | Chief Financial Officer | 08/01/2022 | 12,113 |
| Russo Thomas Joseph | Chief Financial Officer | 07/29/2022 | 4,542 |
| Holtzman Douglas | Chief Scientific Officer | 08/02/2022 | 3,037 |
| Holtzman Douglas | Chief Scientific Officer | 08/01/2022 | 61,973 |
| Holtzman Douglas | Chief Scientific Officer | 07/29/2022 | 4,158 |
| Richardson Charles E | SVP, Technical Operations | 08/02/2022 | 2,487 |
| Richardson Charles E | SVP, Technical Operations | 08/01/2022 | 9,080 |
| Richardson Charles E | SVP, Technical Operations | 07/29/2022 | 3,405 |
| Kanesa-thasan Niranjan | Chief Medical Officer | 08/02/2022 | 3,640 |
| Kanesa-thasan Niranjan | Chief Medical Officer | 08/01/2022 | 13,281 |
| Kanesa-thasan Niranjan | Chief Medical Officer | 07/29/2022 | 4,982 |
| Cearley Cassia | Chief Business Officer | 08/02/2022 | 2,031 |
| Cearley Cassia | Chief Business Officer | 08/01/2022 | 7,421 |
| Cearley Cassia | Chief Business Officer | 07/29/2022 | 2,779 |
| Simpson Adam K. | Chief Executive Officer | 07/01/2022 | 6,035 |
| MCDADE MARK | Director | 04/01/2022 | 299,797 |
| Simpson Adam K. | Chief Executive Officer | 03/28/2022 | 4,023 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 03/29/2022 | 42,271 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 03/28/2022 | 794,611 |
| Cearley Cassia | Chief Business Officer | 03/18/2022 | 29,515 |
| Cearley Cassia | Chief Business Officer | 03/07/2022 | 171,629 |
| Richardson Charles E | SVP, Technical Operations | 02/14/2022 | 62,188 |
| Kanesa-thasan Niranjan | Chief Medical Officer | 02/02/2022 | 52,101 |
| Simpson Adam K. | Chief Executive Officer | 01/26/2022 | 90,968 |
| Cearley Cassia | Chief Business Officer | 11/15/2021 | 18,756 |
| NanoDimension III, L.P. | Former 10% Owner | 08/02/2021 | 2,000,010 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 08/02/2021 | 39,999,990 |
| Gould Terry P | Director | 08/02/2021 | 2,000,010 |
| ADAMS STREET PARTNERS LLC | Former 10% Owner | 08/02/2021 | 2,000,010 |
| Richardson Charles E | See Remarks | 07/30/2021 | 416,250 |
| Cearley Cassia | Chief Business Officer | 07/30/2021 | 416,250 |
| Veneman Ann M | Director | 07/30/2021 | 127,500 |
| Qiming U.S. Healthcare Fund II, L.P. | Former 10% Owner | 08/02/2021 | 3,320,265 |
| Holtzman Douglas | Chief Scientific Officer | 07/30/2021 | 622,500 |
| FIELDS HEIDI | Director | 07/30/2021 | 131,250 |
| Simpson Adam K. | Chief Executive Officer | 07/30/2021 | 1,875,000 |
| Kanesa-thasan Niranjan | Chief Medical Officer | 07/30/2021 | 622,500 |
| Kanesa-thasan Niranjan | Chief Medical Officer | 08/02/2021 | 99,990 |
| Russo Thomas Joseph | Chief Financial Officer | 07/30/2021 | 487,500 |
| Sanofi | 10% Owner | 08/02/2021 | 1,000,005 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR ICOSAVAX, INC.
STOCK BUYBACKS FOR ICOSAVAX, INC.
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
11.75%
1Q
03/31/2023
21.24%
2Q
12/31/2022
24.98%
3Q
09/30/2022
25.87%
4Q
06/30/2022
26.36%
5Q
03/31/2022
26.98%
6Q
09/30/2021
88.83%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ICOSAVAX, INC.
LOADING...